These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 20440544)

  • 1. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
    Radisky ES; Radisky DC
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):201-12. PubMed ID: 20440544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA; Parvani JG; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs and EMT in mammary cells and breast cancer.
    Wright JA; Richer JK; Goodall GJ
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):213-23. PubMed ID: 20499142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB/EGF signaling and EMT in mammary development and breast cancer.
    Hardy KM; Booth BW; Hendrix MJ; Salomon DS; Strizzi L
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):191-9. PubMed ID: 20369376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
    Micalizzi DS; Farabaugh SM; Ford HL
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.
    Godde NJ; Galea RC; Elsum IA; Humbert PO
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):149-68. PubMed ID: 20461450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
    Creighton CJ; Chang JC; Rosen JM
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):253-60. PubMed ID: 20354771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression.
    de Herreros AG; Peiró S; Nassour M; Savagner P
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):135-47. PubMed ID: 20455012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-to-mesenchymal transitions and circulating tumor cells.
    Bonnomet A; Brysse A; Tachsidis A; Waltham M; Thompson EW; Polette M; Gilles C
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):261-73. PubMed ID: 20449641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail.
    Cichon MA; Radisky DC
    Oncotarget; 2014 May; 5(9):2827-38. PubMed ID: 24811539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary gland studies as important contributors to the cause of epithelial mesenchymal plasticity in malignancy.
    Ford HL; Thompson EW
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):113-5. PubMed ID: 20544376
    [No Abstract]   [Full Text] [Related]  

  • 12. Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail's pace.
    Przybylo JA; Radisky DC
    Int J Biochem Cell Biol; 2007; 39(6):1082-8. PubMed ID: 17416542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
    Radisky ES; Raeeszadeh-Sarmazdeh M; Radisky DC
    J Cell Biochem; 2017 Nov; 118(11):3531-3548. PubMed ID: 28585723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-induced malignancy in mammary epithelial cells.
    Stallings-Mann M; Radisky D
    Cells Tissues Organs; 2007; 185(1-3):104-10. PubMed ID: 17587815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathology of EMT in mouse mammary tumorigenesis.
    Cardiff RD
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):225-33. PubMed ID: 20521088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-induced fibrosis and malignancy in breast and lung.
    Radisky DC; Przybylo JA
    Proc Am Thorac Soc; 2008 Apr; 5(3):316-22. PubMed ID: 18403326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncanonical TGF-β signaling during mammary tumorigenesis.
    Parvani JG; Taylor MA; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.
    Chakrabarti R; Hwang J; Andres Blanco M; Wei Y; Lukačišin M; Romano RA; Smalley K; Liu S; Yang Q; Ibrahim T; Mercatali L; Amadori D; Haffty BG; Sinha S; Kang Y
    Nat Cell Biol; 2012 Nov; 14(11):1212-22. PubMed ID: 23086238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
    Coussens LM; Fingleton B; Matrisian LM
    Science; 2002 Mar; 295(5564):2387-92. PubMed ID: 11923519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT).
    Blavier L; Lazaryev A; Shi XH; Dorey FJ; Shackleford GM; DeClerck YA
    Cancer Biol Ther; 2010 Jul; 10(2):198-208. PubMed ID: 20534975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.